- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03720106
The Way to Goal-oriented Therapy Planning in Neurorehabilitation
The Way to Goal-oriented Therapy Planning in Neurorehabilitation: Adherence to Targeted Clinical Pathways in Subacute Stroke- a Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
According to Feigin and employees, in 2013 there were 25.7 million people worldwide who survived a stroke. In order to regain independence in everyday life after a mild to severe stroke, a rehabilitation phase is recommended. Rehabilitation is a holistic process with the aim of maximising participation in the daily life of the affected person. Tailor-made interventions with a focus on impairment, activity and participation should be carried out for this purpose. The International Classification of Functioning, Disability and Health (ICF) was developed in a worldwide consensus and declared by the WHO as a generally accepted framework for describing function and health. In rehabilitation, it is considered as standard and is used to speak a uniform language between the disciplines, to understand the needs of patients, to adapt the corresponding interventions to the needs and to measure outcomes. In order to optimally plan the process, Stroke Guidelines recommend to define goals together with the patient and to use standardized and valid assessments. So far, the following assessments have been used for the neurorehabilitation of stroke patients: Barthel Index, Functional Independence Measure and Functional Assessment Measure as well as the Modified Ranking Scale, but according to Ottiger and her colleagues there was a lack of multidisciplinary assessments with good psychometric properties and which are based on ICF. For this reason, the ICF-based multidisciplinary observation scale (LIMOS) was developed in Lucerne. It consists of four multidisciplinary components based on the following ICF domains: motor function, cognition, communication and coping with everyday life. Due to its good psychometric properties, LIMOS was recommended as a multidisciplinary assessment for neurorehabilitation. The Rehabilitation Clinic Zihlschlacht (RZS) has an interprofessional team. Each discipline carries out subject-specific assessments and plans the necessary therapy units based on empirical values. So far, however, there has been no algorithm that records the deficits of a stroke patient on an interdisciplinary basis and uses the results to determine the main therapeutic areas. In RZS, patient satisfaction with the therapy plan in 2017 was 77%. The reasons for dissatisfaction were: Lack of inclusion of needs, lack of adaptation to changing needs, time aspects, lack of information and the proportion of cognitive and motor therapies. Now the therapy planning system is to be optimized. The LIMOS classification should help to record the patient in an interdisciplinary manner and to visualize focal points. Together with the patient, goals are discussed which are weighted on the basis of LIMOS. These results, together with evidence-based subject-specific treatment pathways, are integrated into an algorithm (GOAL) that creates a goal-oriented treatment plan.
The aim of this feasibility study is to investigate whether target-oriented treatment planning can be maintained in the rehabilitation of stroke patients using the existing classification and evidence-based specialist treatment pathways. If the goal-oriented treatment planning cannot be adhered to, reasons for failure should be investigated.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zihlschlacht, Switzerland, 8588
- Recruiting
- Rehaklinik Zihlschlacht, Center for Neurological Rehabilitation
-
Contact:
- Caroline Tanner
- Phone Number: +41-71-424 3759
- Email: c.tanner@rehaklinik-zihschlacht.ch
-
Contact:
- Carsten Möller, MD
- Email: c.möller@rehaklinik-zihlschlacht.ch
-
Sub-Investigator:
- Oliver Stoller
-
Sub-Investigator:
- Raoul Schweinfurther
-
Sub-Investigator:
- Evelin Lüchinger
-
Sub-Investigator:
- Nathalie Hollenstein
-
Sub-Investigator:
- Bettina Lüchinger
-
Sub-Investigator:
- Anja Locher
-
Sub-Investigator:
- Anna Coppers
-
Sub-Investigator:
- Sebastian Jehle
-
Sub-Investigator:
- Svenja Glönkler
-
Sub-Investigator:
- Bettina Arca
-
Sub-Investigator:
- Stephanie Rabiega
-
Sub-Investigator:
- Manuela Möller
-
Sub-Investigator:
- Simon Hirsiger
-
Sub-Investigator:
- Peggy Tiebel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- clinical diagnosis of ischemic (e.g., anterior, middle or posterior cerebral artery, cerebellar arteries) or haemorrhagic stroke
- subacute stage: 2 weeks to 6 months after the event7
- signed declaration of consent
Exclusion Criteria:
- other cerebrovascular events (sinus vein thrombosis or subarachnoid haemorrhage)
- participation in other intervention studies
- any medical conditions that interfere with the patient's ability to adhere to the target therapy plan as judged by the sponsor-investigator (e.g., severe dementia)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: treatment arm
In this arm the GOAL therapy plan is used.
|
The GOAL algorithm designs a therapy plan based on the LIMOS assessment, patient goals and subject-specific treatment pathways.
The adherence of this therapy plan is examined.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fidelity
Time Frame: up to 6 months
|
The deviations of the targeted therapy plan are checked weekly on Sunday by the sponsor-investigator.
The deviations are documented in %.
If there are some deviations, the reasons for the deviations are checked and analysed descriptively.
|
up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction: questionnaire of the RZS
Time Frame: 72 hours before discharge of the patient
|
The patient satisfaction is examined using the questionnaire of the RZS.
The results are documented descriptively. the questionnaire contains possible answers to a 5-point likertscale.
1: excellent, 2: very good, 3: good, 4: less good, 5: bad or 1: yes, 2: predominant, 3: partial, 4: rather no, 5: no
|
72 hours before discharge of the patient
|
|
Therapist satisfaction: PSSUQ
Time Frame: 72 hours before discharge of the patient
|
Using the post-study usability questionnaire (PSSUQ), the therapist satisfaction is evaluated and described descriptively.
The rating scale includes a 7-point likert scale with 1: strongly applicable and 7: strongly inapplicable.
|
72 hours before discharge of the patient
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Achievement of longterm goals
Time Frame: 72 hours after admission and 72 hours before discharge of the patient
|
The long-term goals are defined 72 hours after admission and are evaluated 72 hours before discharge of the patient. . The results are dichotomous (1: achieved and 2: not achieved). An overall score in percent is calculated. |
72 hours after admission and 72 hours before discharge of the patient
|
|
Achievement of the overall rehabilitation goals
Time Frame: 72 hours after admission and 72 hours before discharge of the patient
|
The rehabilitation goals are defined within the first week 72 hours after admission in the first rehabilitation meeting and evaluated 72h before discharge according to the national measurement plan of the ANQ.
The scale is dichotomous (1: achieved and 2: not achieved).
An overall score is calculated in %.
The results of the primary outcome "Fidelity" are used to examine possible correlations with the results of the goal achievement (long-term goals and rehab goals).
The value 1 stands for a strong correlation, while the value 0 stands for no correlation.
|
72 hours after admission and 72 hours before discharge of the patient
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Caroline Tanner, Rehaklinik Zihlschlacht
Publications and helpful links
General Publications
- Feigin VL, Norrving B, George MG, Foltz JL, Roth GA, Mensah GA. Prevention of stroke: a strategic global imperative. Nat Rev Neurol. 2016 Sep;12(9):501-12. doi: 10.1038/nrneurol.2016.107. Epub 2016 Jul 22.
- Cieza A, Ewert T, Ustun TB, Chatterji S, Kostanjsek N, Stucki G. Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med. 2004 Jul;(44 Suppl):9-11. doi: 10.1080/16501960410015353.
- Weimar C, Kurth T, Kraywinkel K, Wagner M, Busse O, Haberl RL, Diener HC; German Stroke Data Bank Collaborators. Assessment of functioning and disability after ischemic stroke. Stroke. 2002 Aug;33(8):2053-9. doi: 10.1161/01.str.0000022808.21776.bf.
- Ottiger B, Vanbellingen T, Gabriel C, Huberle E, Koenig-Bruhin M, Pflugshaupt T, Bohlhalter S, Nyffeler T. Validation of the new Lucerne ICF based Multidisciplinary Observation Scale (LIMOS) for stroke patients. PLoS One. 2015 Jun 25;10(6):e0130925. doi: 10.1371/journal.pone.0130925. eCollection 2015. Erratum In: PLoS One. 2015;10(7):e0134186. Plugshaupt, Tobias [corrected to Pflugshaupt, Tobias].
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RZS_01_2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Triage
-
Kepler University HospitalCompleted
-
Turku University HospitalUnknownArtificial Intelligence | Triage
-
University of CatanzaroAzienda Ospedaliero Universitaria Renato DulbeccoActive, not recruiting
-
Andreas MeerCantonal Hospital of BadenCompleted
-
Emergency Medical Services, Capital Region, DenmarkRigshospitalet, Denmark; University of Copenhagen; Copenhagen University Hospital... and other collaboratorsCompletedEfficacy, Self | Pediatrics | TriageDenmark
-
M.D. Anderson Cancer CenterCompleted
-
Sophiahemmet UniversityFalck Ambulance A/S; CrashCourse AB; Laerdal Medical Foundation; Ambulance Service...CompletedTraining | Triage | Learning | Mass Casualty IncidentSweden
-
University Medical Centre MariborRecruitingEmergency Medicine | Triage | Emergency Department Triage | Emergency Department OvercrowdingSlovenia
-
sureyya gumussoyEge UniversityNot yet recruitingEXAMINATION OF THE EFFECTIVENESS OF GAME-BASED LEARNING METHOD IN START TRIAGE TRAINING IN DISASTERSPre-hospital Triage | Game-Based Learning | Paramedical Professionals
Clinical Trials on GOAL therapy plan
-
National Taiwan University HospitalCompletedPostoperative Cognitive Dysfunction | AnesthesiaTaiwan
-
University of CalgaryUniversity of AlbertaCompleted
-
Homewood Research InstituteSt. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research (CIHR) and other collaboratorsRecruitingPost Traumatic Stress Disorder | Cognitive DeficitCanada
-
Medical University of South CarolinaTerminatedEsophageal CancerUnited States
-
University of California, IrvineCompletedPostoperative ComplicationUnited States
-
Brno University HospitalCompleted
-
Medical University of ViennaCompleted
-
University of Maryland, BaltimoreNot yet recruitingAcute Kidney Injury | Renal Injury
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Helsinki University Central HospitalCompletedPostoperative Complications